Literature DB >> 15532827

Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases.

Dominique Elias1, Roberto Santoro, Jean-Francois Ouellet, Liliana Osmak, Thierry de Baere, Alain Roche.   

Abstract

BACKGROUND/AIMS: Hepatic resection offers the best chance of survival for patients with liver metastases (LM) of colorectal origin. However, some patients are not eligible for surgery because of a too small future liver remnant (FLR) which carries a high risk of severe postoperative liver failure. The operability status of these patients can be favorably changed by selective right portal vein embolization (PVE) which induces compensatory growth of the left liver. However, during liver regeneration following right PVE, the left LM growth rate is faster than that of the non-embolized normal liver parenchyma. This study aimed at examining an approach for those patients in which there is bilateral LM potentially resectable following portal vein embolization, but in which there is a risk of rapid liver metastasis growth in the non-embolized liver.
METHODOLOGY: Between October 1998 and January 2001, 5 patients underwent simultaneous right PVE and radiofrequency ablation (RFA) of a left LM, prior to a major right-sided hepatectomy for initially unresectable bilateral LM. All these patients had one LM in the left liver in addition with multiple LM in the right liver. Simultaneous right PVE and left RFA was performed percutaneously under intravenous sedation and analgesia. One month later, hepatectomy was undertaken. To allow histologic assessment of the RFA effectiveness, the previously treated left-sided tumor was also resected and analyzed.
RESULTS: Simultaneous PVE-RFA was successful in all patients. No tumor growth on the RFA site was observed during the interval between PVE-RFA and surgery. Histologic examination showed complete tumor sterilization of the RFA necrotic zone. In the postoperative course, 1 patient died of acute liver failure. For the 4 remaining patients, morbidity was minimal (transient bile leak in one patient).
CONCLUSIONS: Simultaneous percutaneous right PVE and left RFA is feasible. This procedure allowed good left-sided tumor control during liver growth following PVE in all five patients. It is the most logical procedure for patients with bilateral colorectal LM needing right PVE before resection, if the left concomitant LM is small and accessible to percutaneous RFA. This procedure should be preferred because it eliminates the risk of left LM growth during the 1-month interval between PVE and surgery.

Entities:  

Mesh:

Year:  2004        PMID: 15532827

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  10 in total

Review 1.  Small for size liver remnant following resection: prevention and management.

Authors:  Rony Eshkenazy; Yael Dreznik; Eylon Lahat; Barak Bar Zakai; Alex Zendel; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

Review 2.  Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.

Authors:  Mathias Worni; Kevin N Shah; Bryan M Clary
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

3.  Strategies for resection using portal vein embolization: metastatic liver cancer.

Authors:  Dominique Elias; Diane Goere; Niaz Kohneh-Sahrhi; Thierry de Baere
Journal:  Semin Intervent Radiol       Date:  2008-06       Impact factor: 1.513

4.  Practical questions in liver metastases of colorectal cancer: general principles of treatment.

Authors:  Héctor Daniel González; Joan Figueras
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 5.  Tumour progression and liver regeneration--insights from animal models.

Authors:  Chetana Lim; Francois Cauchy; Daniel Azoulay; Olivier Farges; Maxime Ronot; Marc Pocard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-09       Impact factor: 46.802

6.  Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis.

Authors:  Mingzhe Weng; Yong Zhang; Di Zhou; Yong Yang; Zhaohui Tang; Mingning Zhao; Zhiwei Quan; Wei Gong
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

7.  Milestones in the evolution of hepatic surgery.

Authors:  Henri Bismuth; Rony Eshkenazy; Arie Arish
Journal:  Rambam Maimonides Med J       Date:  2011-01-31

8.  Combining partial liver resection and local ablation of liver tumours: a preliminary Dutch experience.

Authors:  Bram Fioole; Maarten C Jansen; Frederieke H van Duijnhoven; Richard van Hillegersberg; Thomas M van Gulik; Inne Hm Borel Rinkes
Journal:  World J Surg Oncol       Date:  2006-07-17       Impact factor: 2.754

Review 9.  Centralization of Liver Cancer Surgery and Impact on Multidisciplinary Teams Working on Stage IV Colorectal Cancer.

Authors:  Elroy Patrick Weledji
Journal:  Oncol Rev       Date:  2017-07-31

Review 10.  What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review.

Authors:  Samuel Frey; Eric Mirallié; Maëlle Le Bras; Nicolas Regenet
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.